Cantor Fitzgerald Upgrades Prothena (NASDAQ:PRTA) to Strong-Buy
Cantor Fitzgerald upgraded shares of Prothena (NASDAQ:PRTA – Free Report) to a strong-buy rating in a research report released on Tuesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Prothena’s FY2025 earnings at ($3.59) EPS. PRTA has been the subject of several other reports. Oppenheimer lifted their price target on shares of Prothena from $58.00 to […]
Cantor Fitzgerald upgraded shares of Prothena (NASDAQ:PRTA – Free Report) to a strong-buy rating in a research report released on Tuesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Prothena’s FY2025 earnings at ($3.59) EPS. PRTA has been the subject of several other reports. Oppenheimer lifted their price target on shares of Prothena from $58.00 to […]
